Abstract:Vasculogenic mimicry (VM) serves as a vascular-like channel that provides important substances for tumor growth and is a primary factor in glioblastoma (GBM) drug resistance. Human Antigen R (HuR)-an mRNA-binding protein-is highly expressed in GBM, closely related to tumor progression, and deemed a potential drug target. Although some small-molecule compounds have been identified to disrupt HuR binding to target mRNA, they remain in the preclinical research stage, suggesting the need for further validation and development of HuR inhibitors. In our study, we aim to screen for potential HuR inhibitors and investigate their efficacy and molecular mechanisms in GBM. We employed the fluorescence polarization method to identify HuR inhibitors from a natural compound library, confirming the efficacy of juglone in effectively inhibiting the binding of HuR to AREVegf-a. Further validation of the binding of juglone to HuR at the protein level was conducted through electrophoretic mobility shift analysis, surface plasmon resonance, and molecular docking. Furthermore, juglone demonstrated inhibitory effects on glioma growth and VM formation in vitro and in vivo. Moreover, it was observed that juglone reversed epithelial-mesenchymal transition by inhibiting the VEGF-A/VEGFR2/AKT/SNAIL signaling pathway. Finally, we established the capability of juglone to target HuR in U251 cells through HuR knockdown, mRNA stability, and cell thermal shift assays. Therefore, this study identifies juglone as a novel HuR inhibitor, potentially offering promise as a lead compound for anti-VM therapy in GBM by targeting HuR. Abbreviations: AKT, protein kinase B; ARE, adenine-and uridine-rich elements; CETSA, cellular thermal shift assay; DMEM, Dulbecco's modified Eagle's medium; ELISA, enzyme linked immune sorbent assay; EMSA, electrophoretic mobility shift assay; EMT, epithelial mesenchymal transition; FP, fluorescence polarization; GBM, glioblastoma; HTS, high-throughput screening; HuR, human antigen R; IF, Immunofluorescence; PAS, periodic acid-Schiff; PI3K, phosphoinositide-3 kinase; qRT-PCR, quantitative real-time PCR; RRMs, RNA recognition motifs; SPR, surface plasmon resonance. TMZ, temozolomide; VM, vasculogenic mimicry; VEGF-A, Vascular endothelial growth factor-A; VEGFR2, Vascular endothelial growth factor receptor-2.

Juglone Reduces Growth and Migration of U251 Glioblastoma Cells and Disrupts Angiogenesis

The Anti-Glioma Effect of Juglone Derivatives through ROS Generation

Juglone Inhibits Tumor Metastasis by Regulating Stemness Characteristics and the Epithelial-to-Mesenchymal Transition in Cancer Cells both in Vitro and in Vivo

Juglone suppresses vasculogenic mimicry in glioma through inhibition of HuR-mediated VEGF-A expression

Inhibition of human leukemia cells growth by juglone is mediated via autophagy induction, endogenous ROS production, and inhibition of cell migration and invasion.

Juglone, from Juglans mandshruica Maxim, inhibits growth and induces apoptosis in human leukemia cell HL-60 through a reactive oxygen species-dependent mechanism

Pin1 inhibitor juglone induces apoptosis in human cervical cancer SiHa cells

Juglone Induces Apoptosis of Tumor Stem-Like Cells Through ROS-p38 Pathway in Glioblastoma.

Juglone in Combination with Temozolomide Shows a Promising Epigenetic Therapeutic Effect on the Glioblastoma Cell Line

Juglone Effects by Dual Way on mTOR Gene Expression, Which Plays Central Role in Cell Growth, Survival and Metabolism, in PANC-1 and BxPC-3 Pancreatic Cancer Cell Lines

Juglone, Isolated from Juglans Mandshurica Maxim, Induces Apoptosis Via Down-Regulation of AR Expression in Human Prostate Cancer LNCaP Cells

Structure‐based JAZ Ligand‐j1 and Its Analogues Show Strong Cytotoxic Effects on Glioma Cells in Vitro ‐ A New Class of Glioma Therapy Drugs?

Anti-proliferative Effect of Juglone from Juglans Mandshurica Maxim on Human Leukemia Cell HL-60 by Inducing Apoptosis Through the Mitochondria-Dependent Pathway

Juglone Inhibits Proliferation and Induces Apoptosis of Human Cervical Squamous Cancer SiHa Cells

Juglone Potentiates BRAF Inhibitor‑induced Apoptosis in Melanoma Through Reactive Oxygen Species and the P38‑p53 Pathway

Juglone induces ferroptosis in glioblastoma cells by inhibiting the Nrf2-GPX4 axis through the phosphorylation of p38MAPK

Juglone Potentiates TRAIL-induced Apoptosis in Human Melanoma Cells Via Activating the ROS-p38-p53 Pathway

Inhibitory effect of juglone on proliferation of leukemia cells

Growth Inhibitory in Vitro Effects of Glycyrrhizic Acid in U251 Glioblastoma Cell Line

Juglanin ameliorates UVB‑induced skin carcinogenesis via anti‑inflammatory and proapoptotic effects in vivo and in vitro

[Proliferation inhibition and apoptosis induction of Juglone on human cervical cancer Caski cells].